fulvestrant has been researched along with Coronary Artery Disease in 1 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Agrogiannis, G; Castanas, E; Deli, A; Kampa, M; Kiagiadaki, F; Notas, G; Patsouris, E; Pelekanou, V; Theodoropoulos, P; Tsapis, A | 1 |
1 other study(ies) available for fulvestrant and Coronary Artery Disease
| Article | Year |
|---|---|
Estrogen anti-inflammatory activity on human monocytes is mediated through cross-talk between estrogen receptor ERĪ±36 and GPR30/GPER1.
Topics: Aged; Anti-Inflammatory Agents; Cell Line, Tumor; Cell Nucleus; Coronary Artery Disease; Dendritic Cells; Estradiol; Estrogen Receptor alpha; Female; Foam Cells; Fulvestrant; Genes, Reporter; Humans; Inflammation; Interleukin-6; Lipopolysaccharides; Macrophages; Male; Middle Aged; Monocytes; Myelopoiesis; Protein Interaction Mapping; Protein Isoforms; Receptor Cross-Talk; Receptors, Estrogen; Receptors, G-Protein-Coupled; RNA Interference; RNA, Small Interfering; Transcription Factor RelA; Transcription, Genetic | 2016 |